4basebio UK Societas - UK-based biotech company - Files a patent application for a novel protected and stabilised linear synthetic DNA type, osDNA. "We see real opportunity to position osDNA as a key input for mRNA and DNA vaccine production, an area of the rapidly growing gene therapy and vaccine market attracting significant attention," says Chief Executive & Chief Scientific Officer Heikki Lanckriet.
Current stock price: 400.00 pence
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
4basebio Plc (4BB)